| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |